MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy

THE STOPPING AND RANGE OF IONS IN SOLIDS

Ziegler, J. F. (1988) · Elsevier eBooks · doi:10.1016/b978-0-12-780621-1.50005-8 · Cited by 9,077

THE STOPPING AND RANGE OF IONS IN SOLIDS

Ziegler, J. F. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-780620-4.50007-0 · Cited by 5,892

Recommendations of the International Commission on Radiological Protection

(1961) · Postgraduate Medical Journal · doi:10.1136/pgmj.37.425.168-b · Cited by 5,868

The Stopping and Range of Ions in Matter

Ziegler, J. F., & Biersack, J. P. (1985) · Springer eBooks · doi:10.1007/978-1-4615-8103-1_3 · Cited by 4,360

Radiobiology for the Radiologist.

(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498

The Stopping and Ranges of Ions in Matter

(1980) · Elsevier eBooks · doi:10.1016/c2013-0-02882-4 · Cited by 3,012

The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy

Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,228

International Commission on Radiological Protection

(1969) · Radiology · doi:10.1148/93.6.1298 · Cited by 2,148

Basic anatomical and physiological data for use in radiological protection: reference values

Valentin, J. (2002) · Annals of the ICRP · doi:10.1016/s0146-6453(03)00002-2 · Cited by 2,024

Report of the task group on reference man

(1979) · Annals of the ICRP · doi:10.1016/0146-6453(79)90123-4 · Cited by 1,715

Age-dependent doses to members of the public from intake of radionuclides: Part 4 Inhalation dose coefficients

Task Group of Committee 2 (1995) · Annals of the ICRP · doi:10.1016/s0146-6453(00)80008-1 · Cited by 1,372

Benefits and costs, an eternal balance

Dixon, A. K. (2007) · Annals of the ICRP · doi:10.1016/j.icrp.2007.09.001 · Cited by 1,355

Homologous recombination and non‐homologous end‐joining pathways of DNA double‐strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells

Takata, M., Sasaki, M. S., Sonoda, E., Morrison, C., Hashimoto, M., Utsumi, H., Yamaguchi‐Iwai, Y., Shinohara, A., & Takeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5497 · Cited by 1,229

Initial Events in the Cellular Effects of Ionizing Radiations: Clustered Damage in DNA

Goodhead, D. T. (1994) · International Journal of Radiation Biology · doi:10.1080/09553009414550021 · Cited by 1,204

TABLE OF RADIOACTIVE ISOTOPES

Firestone, R. B., & Browne, E. (1998) · Elsevier eBooks · doi:10.1016/b978-0-12-436255-0.50019-8 · Cited by 1,081

Induction of sister chromatid exchanges by extremely low doses of alpha-particles.

Nagasawa, H., & Little, J. B. (1992) · PubMed · Cited by 995

MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature

Bolch, W. E., Eckerman, K. F., Sgouros, G., & Thomas, S. R. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056036 · Cited by 913

THE INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS

Wambersie, A. (2004) · Journal of the ICRU · doi:10.1093/jicru/ndh019 · Cited by 870

Recommendations of the International Commission on Radiological Protection Publication 60

Icrp (1991) · Annals of the ICRP · Cited by 835

Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.

Jain, R. K., & Baxter, L. T. (1988) · PubMed · Cited by 710

Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells

Azzam, E. I., de Toledo, S. M., & Little, J. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011417098 · Cited by 638

Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom.

Ws, S., Hl, F., Mr, F., & Warner, G. G. (1969) · PubMed · Cited by 627

Comments on ICRU Report No. 49: Stopping Powers and Ranges for Protons and Alpha Particles

Ziegler, J. F. (1999) · Radiation Research · doi:10.2307/3580097 · Cited by 626

National Technical Information Service

Holcombe, S. L. (2008) · Reference Reviews · doi:10.1108/09504120810872238 · Cited by 611

1990 Recommendations of the International Commission on Radiological Protection.

(1991) · PubMed · Cited by 602

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

Siegel, J. A., Thomas, S. R., Stubbs, J. B., Mg, S., Hays, M. T., Koral, K. F., Robertson, J. S., Howell, R. W., Wessels, B. W., Fisher, D. R., et al. (1999) · PubMed · Cited by 572

MIRD primer for absorbed dose calculations

LOEVINGER, R., Budinger, T. F., & Watson, E. E. (1988) · Medical Entomology and Zoology · Cited by 552

Intercellular Communication Is Involved in the Bystander Regulation of Gene Expression in Human Cells Exposed to Very Low Fluences of Alpha Particles

Azzam, E. I., de Toledo, S. M., Gooding, T. B., & Little, J. B. (1998) · Radiation Research · doi:10.2307/3579865 · Cited by 521

Relative biological effectiveness (RBE), quality factor ( Q ), and radiation weighting factor ( w R ): ICRP Publication 92: Approved by the Commission in January 2003

Valentin, J. (2003) · Annals of the ICRP · doi:10.1016/s0146-6453(03)00024-1 · Cited by 521

Radiation-Induced Bystander Effects: Past History and Future Directions

Mothersill, C. E., & Seymour, C. B. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0759:ribeph]2.0.co;2 · Cited by 511

Tumor therapy with targeted atomic nanogenerators.

McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study

Nilsson, S. F., Franzén, L., Parker, C. C., Tyrrell, C., Blom, R., Tennvall, J., Lennernäs, B., Petersson, U., Johannessen, D. C., Sokal, M., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70147-x · Cited by 493

Induction of a bystander mutagenic effect of alpha particles in mammalian cells

Zhou, H., Randers-Pehrson, G., Waldren, C. A., Vannais, D. B., Hall, E. J., & Hei, T. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030420797 · Cited by 478

Targeted α particle immunotherapy for myeloid leukemia

Jurcic, J. G., Larson, S. M., Sgouros, G., McDevitt, M. R., Finn, R. D., Divgi, C. R., Ballangrud, Å., Hamacher, K. A., Ma, D., Humm, J. L., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1233.h81602001233_1233_1239 · Cited by 472

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Moscatello, D. K., Pegram, C. N., & Reist, C. J. (1995) · PubMed · Cited by 469

First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases

Nilsson, S. F., Larsen, R. H., Fosså, S. D., Balteskard, L., Borch, K. W., Westlin, J., Salberg, G., & Bruland, Ø. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2244 · Cited by 439

Clinical Experience with α-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

Zalutsky, M. R., Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., McLendon, R. E., Wong, T. Z., & Bigner, D. D. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046938 · Cited by 414

Radioimmunotherapy with alpha-emitting nuclides

McDevitt, M. R., Sgouros, G., Finn, R. D., Humm, J. L., Jurcic, J. G., Larson, S. M., & Scheinberg, D. A. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050306 · Cited by 403

Transport of fluid and macromolecules in tumors

Baxter, L. T., & Jain, R. K. (1991) · Microvascular Research · doi:10.1016/0026-2862(91)90003-t · Cited by 391

Current Topics in Radiation Research

Elkind, M. M. (1968) · Radiology · doi:10.1148/91.4.831b · Cited by 376

High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the α-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities?

Bruland, Ø. S., Nilsson, S. F., Fisher, D. R., & Larsen, R. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0841 · Cited by 356

Radiation biology in cancer research

(1978) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(78)90242-6 · Cited by 336

The hypoxia-inducible factor-1α is a negative factor for tumor therapy

Unruh, A., Ressel, A., Mohamed, H. G., Johnson, R. S., Nadrowitz, R., Richter, E., Katschinski, D. M., & Wenger, R. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206385 · Cited by 334

The radiobiology of radiosurgery: Rationale for different treatment regimes for AVMs and malignancies

Hall, E. J., & Brenner, D. J. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90367-5 · Cited by 308

Radioactive iodine therapy

Lee, S. L. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328357fa0c · Cited by 307

ICRP Publication 23

Richmond, C. R. (1985) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553008514551281 · Cited by 306

Ion Implantation Science and Technology

(1988) · Elsevier eBooks · doi:10.1016/b978-0-12-780621-1.x5001-1 · Cited by 303

Bone marrow dosimetry for radioimmunotherapy: theoretical considerations.

Sgouros, G. (1993) · PubMed · Cited by 298

Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic

Shepard, H. M., Phillips, G. D. L., Sarup, J. C., FENDLY, B. M., Maneval, D. C., Mordenti, J. J., Figari, I. S., Kotts, C. E., Palladino, M. A., Ullrich, A., et al. (1991) · Journal of Clinical Immunology · doi:10.1007/bf00918679 · Cited by 295

Normal Variations with Aging of the Amount of Hematopoietic Tissue in Bone Marrow from the Anterior Iliac Crest: A Study Made from 177 Cases of Sudden Death Examined by Necropsy

Hartsock, R. J., Smith, E. B., & Petty, C. S. (1965) · American Journal of Clinical Pathology · doi:10.1093/ajcp/43.4.326 · Cited by 294

Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies

Brechbiel, M. W., Gansow, O. A., Atcher, R. W., Schlom, J., Esteban, J. M. R., Simpson, D., & Colcher, D. M. (1986) · Inorganic Chemistry · doi:10.1021/ic00236a024 · Cited by 290

Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.

Henriksen, G., Breistøl, K., Bruland, Ø. S., Fodstad, Ø., & Larsen, R. H. (2002) · PubMed · Cited by 279

Constraints on Energy Deposition and Target Size of Multiply Damaged Sites Associated with DNA Double-strand Breaks

Brenner, D. J., & Ward, J. F. (1992) · International Journal of Radiation Biology · doi:10.1080/09553009214551591 · Cited by 279

The Effect of Oxygen on Impairment of the Proliferative Capacity of Human Cells in Culture by Ionizing Radiations of Different LET

Barendsen, G. W., Koot, C. J., van Kersen, G. R., Bewley, D. K., Field, S. B., & Parnell, C. J. (1966) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553006614550421 · Cited by 264

Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

Larson, S. M., Carrasquillo, J. A., Krohn, K., BROWN, J. P., McGuffin, R. W., Ferens, J. M., Graham, M. M., Hill, L., Beaumier, P. L., & Hellström, K. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111175 · Cited by 259

An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.

McDevitt, M. R., Barendswaard, E., Ma, D., Lai, L. T., Curcio, M. J., Sgouros, G., Ballangrud, Å., Yang, W., Finn, R. D., Pellegrini, V., et al. (2000) · PubMed · Cited by 259

Effects of Different Ionizing Radiations on Human Cells in Tissue Culture: II. Biological Experiments

Barendsen, G. W., Beusker, T. L. J., Vergroesen, A. J., & Budke, L. (1960) · Radiation Research · doi:10.2307/3570859 · Cited by 258

Calculation of Initial Yields of Single- and Double-strand Breaks in Cell Nuclei from Electrons, Protons and Alpha Particles

Charlton, D. E., Nikjoo, H., & Humm, J. L. (1989) · International Journal of Radiation Biology · doi:10.1080/09553008914551141 · Cited by 252

Mutation and Inactivation of Cultured Mammalian Cells Exposed to Beams of Accelerated Heavy Ions

Thacker, J., Stretch, A., & Stephens, M. A. (1979) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553007914550891 · Cited by 251

The Relation Between Tumour Lethal Doses and the Radiosensitivity of Tumour Cells

Munro, T. R., & Gilbert, C. W. (1961) · British Journal of Radiology · doi:10.1259/0007-1285-34-400-246 · Cited by 251

Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice.

Henriksen, G., Fisher, D. R., Roeske, J. C., Bruland, Ø. S., & Larsen, R. H. (2003) · PubMed · Cited by 250

Design and synthesis of 225Ac radioimmunopharmaceuticals.

McDevitt, M. R., Ma, D., Simon, J., Frank, R. K., & Scheinberg, D. A. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00167-7 · Cited by 225

The promise of targeted {alpha}-particle therapy.

Mulford, D. A., Scheinberg, D. A., & Jurcic, J. G. (2005) · PubMed · Cited by 223

Non-targeted bystander effects induced by ionizing radiation

Morgan, W. F., & Sowa, M. B. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.11.009 · Cited by 219

THE BYSTANDER EFFECT

Hall, E. J. (2003) · Health Physics · doi:10.1097/00004032-200307000-00008 · Cited by 218

Production of Ac-225 from Th-229 for Targeted α Therapy

Apostolidis, C., Molinet, R., Rasmussen, G., & Morgenstern, A. (2005) · Analytical Chemistry · doi:10.1021/ac0580114 · Cited by 215

Effects of Different Ionizing Radiations on Human Cells in Tissue Culture: III. Experiments with Cyclotron-Accelerated Alpha-Particles and Deuterons

Barendsen, G. W., Walter, H. M. D., Fowler, J. F., & Bewley, D. K. (1963) · Radiation Research · doi:10.2307/3571430 · Cited by 211

Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.

Sgouros, G., Ballangrud, Å., Jurcic, J. G., McDevitt, M. R., Humm, J. L., Erdi, Y. E., Mehta, B. M., Finn, R. D., Larson, S. M., & Scheinberg, D. A. (1999) · PubMed · Cited by 207

Astatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle Radiotherapy

Zalutsky, M. R., & Vaidyanathan, G. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399275 · Cited by 203

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.

Kozak, R. W., Atcher, R. W., Gansow, O. A., Friedman, A. M., Hines, J. J., Jr., & Waldmann, T. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.474 · Cited by 197

Introduction

(1991) · Annals of the ICRP · doi:10.1016/0146-6453(91)90065-o · Cited by 190

Induction and Rejoining of DNA Double-strand Breaks in V79-4 Mammalian Cells Following γ- and α-irradiation

Jenner, T. J., deLara, C. M., O'Neill, P., & Stevens, D. L. (1993) · International Journal of Radiation Biology · doi:10.1080/09553009314551421 · Cited by 189

The Relative Radiosensitivity of the Nucleus and Cytoplasm of Chinese Hamster Fibroblasts

Munro, T. R. (1970) · Radiation Research · doi:10.2307/3572962 · Cited by 185

Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.

Nikula, T. K., McDevitt, M. R., Finn, R. D., Wu, C., Kozak, R. W., Garmestani, K., Brechbiel, M. W., Curcio, M. J., Pippin, C. G., Tiffany-Jones, L., et al. (1999) · PubMed · Cited by 176

Cyclotron production of Ac-225 for targeted alpha therapy11Dedicated to Prof. Dr. Franz Baumgärtner on the occasion of his 75th birthday.

Apostolidis, C., Molinet, R., McGinley, J., Abbas, K., Möllenbeck, J., & Morgenstern, A. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.06.013 · Cited by 176

Mird: Radionuclide Data and Decay Schemes

Eckerman, K. F., & Endo, A. (1989) · CERN Document Server (European Organization for Nuclear Research) · Cited by 174

Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments.

Goddu, S. M., Howell, R. W., & Rao, D. V. (1994) · PubMed · Cited by 174

Cancer Stem Cells and Metastasis: Lethal Seeds

Wicha, M. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1537 · Cited by 174

Production of actinium-225 for alpha particle mediated radioimmunotherapy.

Boll, R. A., Malkemus, D., & Mirzadeh, S. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.12.003 · Cited by 171

Radiobiology of α Particles: III. Cell Inactivation by α-Particle Traversals of the Cell Nucleus

Raju, M. R., Eisen, Y., Carpenter, S. G., & Inkret, W. C. T. (1991) · Radiation Research · doi:10.2307/3578139 · Cited by 167

Mutation and Inactivation of Cultured Mammalian Cells Exposed to Beams of Accelerated Heavy Ions IV. Biophysical Interpretation

GOODHEAD, D. T., Munson, R. J., Thacker, J., & Cox, R. (1980) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553008014550201 · Cited by 166

Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields

Lindegren, S., Bäck, T. A., & Jensen, H. J. (2001) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(01)00044-6 · Cited by 161

Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.

Zalutsky, M. R., Garg, P. K., Friedman, H. S., & Bigner, D. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7149 · Cited by 156

Free Radical-Initiated and Gap Junction-Mediated Bystander Effect due to Nonuniform Distribution of Incorporated Radioactivity in a Three-Dimensional Tissue Culture Model

Bishayee, A., Hill, H. Z., Stein, D., Rao, D. V., & Howell, R. W. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0335:friagj]2.0.co;2 · Cited by 156

Radioimmunotherapy with Alpha-Particle-Emitting Immunoconjugates

Macklis, R. M., Kinsey, B. M., Kassis, A. I., Ferrara, J. L. M., Atcher, R. W., Hines, J. J., Jr., Coleman, C. N., Adelstein, S. J., & Burakoff, S. J. (1988) · Science · doi:10.1126/science.2897133 · Cited by 155

Preclinical Evaluation of the α-Particle Generator Nuclide 225Ac for Somatostatin Receptor Radiotherapy of Neuroendocrine Tumors

Miederer, M., Henriksen, G., Alke, A., Mossbrugger, I., Quintanilla-Martinez, L., Senekowitsch-Schmidtke, R., & Essler, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4647 · Cited by 155

Dose-Survival Curves of Human Cells in Tissue Culture Irradiated with Alpha-, Beta-, 20-KV. X- and 200-KV. X-Radiation

Barendsen, G. W. (1962) · Nature · doi:10.1038/1931153a0 · Cited by 153

Local Targeting of Malignant Gliomas by the Diffusible Peptidic Vector 1,4,7,10-Tetraazacyclododecane-1-Glutaric Acid-4,7,10-Triacetic Acid-Substance P

Kneifel, S., Cordier, D., Good, S., Ionescu, M.-C. S., Ghaffari, A., Höfer, S., Kretzschmar, M., Tolnay, M., Apostolidis, C., Waser, B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2820 · Cited by 153

Targeted actinium-225 in vivo generators for therapy of ovarian cancer.

Borchardt, P. E., Yuan, R., Miederer, M., McDevitt, M. R., & Scheinberg, D. A. (2003) · PubMed · Cited by 150

Expression of CONNEXIN43 is highly sensitive to ionizing radiation and other environmental stresses.

Azzam, E. I., de Toledo, S. M., & Little, J. B. (2003) · PubMed · Cited by 148

Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.

Boyd, M., Ross, S. C., Dorrens, J., Fullerton, N., Tan, K. W., Zalutsky, M. R., & Mairs, R. J. (2006) · PubMed · Cited by 145

Transport of fluid and macromolecules in tumors. IV. A microscopic model of the perivascular distribution

Baxter, L. T., & Jain, R. K. (1991) · Microvascular Research · doi:10.1016/0026-2862(91)90026-8 · Cited by 144

Artificially Radioactive Element 85

Corson, D. R., MacKenzie, K. R., & Segre, E. (1940) · Physical Review · doi:10.1103/physrev.58.672 · Cited by 143

Beiträge zur Biologie der Strahlenwirkung

Holthusen, H. (1921) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf01722061 · Cited by 142

MIRD : radionuclide data and decay schemes

Weber, D. A., & Dillman, L. T. (1989) · Society of Nuclear Medicine eBooks · Cited by 141

An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation.

McDevitt, M. R., Finn, R. D., Sgouros, G., Ma, D., & Scheinberg, D. A. (1999) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(98)00151-1 · Cited by 138

Melanoma Therapy via Peptide-Targeted α-Radiation

Miao, Y., Hylarides, M. D., Fisher, D. R., Shelton, T. D., Moore, H. A., WESTER, D. W., Fritzberg, A. R., Winkelmann, C. T., Hoffman, T. J., & Quinn, T. P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0619 · Cited by 136

DNA damage induced by radiation of different linear energy transfer: initial fragmentation

Höglund, E. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138556 · Cited by 135

Alpha-Particle-Induced Increases in the Radioresistance of Normal Human Bystander Cells

Iyer, R. S., & Lehnert, B. E. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0003:apiiit]2.0.co;2 · Cited by 132

Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes

Deal, K. A., Davis, I. A., Mirzadeh, S., Kennel, S. J., & Brechbiel, M. W. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990141f · Cited by 130

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.

Behr, T. M., Béhé, M. P., Stabin, M. G., Wehrmann, E., Apostolidis, C., Molinet, R., Strutz, F., Fayyazi, A., Wieland, E., Gratz, S., et al. (1999) · PubMed · Cited by 127

OCCUPATIONAL POISONING IN MANUFACTURE OF LUMINOUS WATCH DIALS

Martland, H. S. (1929) · JAMA · doi:10.1001/jama.1929.92700320002013 · Cited by 124

Intralesional targeted alpha therapy for metastatic melanoma

Allen, B., Raja, C., Rizvi, S. M., Li, Y., Tsui, W., Graham, P., Thompson, J. A., Reisfeld, R. A., Kearsley, J. H., Morgenstern, A., et al. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.12.2251 · Cited by 124

MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by 213Bi-C595 radioimmunoconjugate

Qu, C., Li, Y., Song, Y. J., Rizvi, S. M., Raja, C., Zhang, D., Samra, J. S., Smith, R. C., Perkins, A. C., Apostolidis, C., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602232 · Cited by 123

Evidence for Pronounced Bystander Effects Caused by Nonuniform Distributions of Radioactivity using a Novel Three-Dimensional Tissue Culture Model

Bishayee, A., Rao, D. V., & Howell, R. W. (1999) · Radiation Research · doi:10.2307/3580054 · Cited by 123

Editorial

(2007) · Annals of the ICRP · doi:10.1016/j.icrp.2008.08.001 · Cited by 123

Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides.

Goddu, S. M., Rao, D. V., & Howell, R. W. (1994) · PubMed · Cited by 122

Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.

Miederer, M., McDevitt, M. R., Sgouros, G., Kramer, K., Cheung, N. V., & Scheinberg, D. A. (2004) · PubMed · Cited by 119

The assessment of RBE effects using the concept of biologically effective dose

Dale, R., & Jones, B. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00364-2 · Cited by 119

Engineered liposomes for potential alpha-particle therapy of metastatic cancer.

Sofou, S., Thomas, J. L., Lin, H. Y., McDevitt, M. R., Scheinberg, D. A., & Sgouros, G. (2004) · PubMed · Cited by 119

Mutation and Inactivation of Cultured Mammalian Cells Exposed to Beams of Accelerated Heavy Ions

Cox, R., & Masson, W. K. (1979) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553007914550901 · Cited by 118

Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labelling of monoclonal antibodies with the bismuth-212 α-particle emitter

Brechbiel, M. W., & Gansow, O. A. (1992) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19920001173 · Cited by 115

A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates

Hui, T. E., Fisher, D. R., Kuhn, J. A., Williams, L. E., Nourigat, C., Badger, C. C., Beatty, B., & Beatty, J. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3+ · Cited by 115

Impairment of the Proliferative Capacity of Human Cells in Culture by α-particles with Differing Linear-energy Transfer

Barendsen, G. W. (1964) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553006414550561 · Cited by 114

Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.

McDevitt, M. R., Finn, R. D., Ma, D., Larson, S. M., & Scheinberg, D. A. (1999) · PubMed · Cited by 112

STUDIES IN IODINE METABOLISM OF THE THYROID GLAND IN SITU BY THE USE OF RADIO-IODINE IN NORMAL SUBJECTS AND IN PATIENTS WITH VARIOUS TYPES OF GOITER

Hamilton, J. G., & Soley, M. H. (1940) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1940.131.1.135 · Cited by 110

A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy

Humm, J. L. (1987) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(87)90176-3 · Cited by 110

Cellular Kinetics, Dosimetry, and Radiobiology of α-Particle Radioimmunotherapy: Induction of Apoptosis

Macklis, R. M., Lin, J. Y., Beresford, B. A., Atcher, R. W., Hines, J. J., Jr., & Humm, J. L. (1992) · Radiation Research · doi:10.2307/3578279 · Cited by 109

The Effect of Dimethyl Sulfoxide on the Induction of DNA Double-Strand Breaks in V79-4 Mammalian Cells by Alpha Particles

deLara, C. M., Jenner, T. J., Townsend, K. M. S., Marsden, S. J., & O’Neill, P. (1995) · Radiation Research · doi:10.2307/3579234 · Cited by 109

Criteria for the Applicability of LET

Kellerer, A. M., & Chmelevsky, D. (1975) · Radiation Research · doi:10.2307/3574148 · Cited by 109

Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection

Dadachova, E., Nakouzi, A. S., Bryan, R. A., & Casadevall, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1731272100 · Cited by 107

The Relationships between RBE and LET for Different Types of Lethal Damage in Mammalian Cells: Biophysical and Molecular Mechanisms

Barendsen, G. W. (1994) · Radiation Research · doi:10.2307/3578823 · Cited by 107

MICROSCOPIC ENERGY DISTRIBUTION IN IRRADIATED MATTER

Rossi, H. H. (1968) · Elsevier eBooks · doi:10.1016/b978-0-12-066401-6.50009-9 · Cited by 107

Radiation Dosimetry of 131I-19-Iodocholesterol: The Pitfalls of Using Tissue Concentration Data—Reply

Kirschner, A. S., Ice, R. D., & Beierwaltes, W. H. (1975) · Journal of Nuclear Medicine · Cited by 107

Effects of Different Ionizing Radiations on Human Cells in Tissue Culture: IV. Modification of Radiation Damage

Barendsen, G. W., & Walter, H. M. D. (1964) · Radiation Research · doi:10.2307/3571569 · Cited by 106

Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids

Ballangrud, Å., Yang, W.-H., Palm, S., Enmon, R. M., Borchardt, P. E., Pellegrini, V., McDevitt, M. R., Scheinberg, D. A., & Sgouros, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0800 · Cited by 106

The centenary of the discovery of the Bragg peak

Brown, A., & Suit, H. D. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.09.008 · Cited by 105

Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction

Larsen, R. H., Wieland, B. W., & Zalutsky, M. R. (1996) · Applied Radiation and Isotopes · doi:10.1016/0969-8043(95)00285-5 · Cited by 105

Comparison of 225actinium chelates: tissue distribution and radiotoxicity

Davis, I. A., Glowienka, K. A., Boll, R. A., Deal, K. A., Brechbiel, M. W., Stabin, M. G., Bochsler, P. N., Mirzadeh, S., & Kennel, S. J. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00024-4 · Cited by 105

Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate

Zalutsky, M. R., & Narula, A. S. (1988) · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · doi:10.1016/0883-2889(88)90176-1 · Cited by 104

213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model

Norenberg, J. P., Krenning, B. J., Konings, I. R. H. M., Kusewitt, D. F., Nayak, T. K., Anderson, T. L., de Jong, M., Garmestani, K., Brechbiel, M. W., & Kvols, L. K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1264 · Cited by 104

Rejoining of DNA fragments produced by radiations of different linear energy transfer

Stenerlöw, B. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138565 · Cited by 104

Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the α-emitting radionuclide, bismuth 213

Zhang, M., Yao, Z., Garmestani, K., Axworthy, D. B., Zhang, Z., Mallett, R. W., Theodore, L. J., Goldman, C. K., Brechbiel, M. W., Carrasquillo, J. A., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0107 · Cited by 103

Efforts to Control the Errant Products of a Targeted In vivo Generator

Singh Jaggi, J., Kappel, B. J., McDevitt, M. R., Sgouros, G., Flombaum, C. D., Cabassa, C., & Scheinberg, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3096 · Cited by 98

Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).

Ballangrud, Å., Yang, W., Charlton, D. E., McDevitt, M. R., Hamacher, K. A., Panageas, K. S., Ma, D., Bander, N. H., Scheinberg, D. A., & Sgouros, G. (2001) · PubMed · Cited by 98

Bismuth 213–labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts

Sandmaier, B. M., Bethge, W. A., Wilbur, D. S., Hamlin, D. K., Santos, E. B., Brechbiel, M. W., Fisher, D. R., & Storb, R. F. (2002) · Blood · doi:10.1182/blood-2001-12-0322 · Cited by 95

The feasibility of 225 Ac as a source of ??-particles in radioimmunotherapy

Geerlings, M. W., Kaspersen, F. M., Apostolidis, C., & van der Hout, R. (1993) · Nuclear Medicine Communications · doi:10.1097/00006231-199302000-00009 · Cited by 95

Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers

Sofou, S., Kappel, B. J., Jaggi, J. S., McDevitt, M. R., Scheinberg, D. A., & Sgouros, G. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070075t · Cited by 94

A Model of Cell Inactivation by Alpha-Particle Internal Emitters

Humm, J. L., & Chin, L. M. (1993) · Radiation Research · doi:10.2307/3578453 · Cited by 92

Renal Tubulointerstitial Changes after Internal Irradiation with α-Particle–Emitting Actinium Daughters

Jaggi, J. S., Seshan, S. V., McDevitt, M. R., LaPerle, K., Sgouros, G., & Scheinberg, D. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110945 · Cited by 89

The Question of Relative Biological Effectiveness and Quality Factor for Auger Emitters Incorporated into Proliferating Mammalian Cells

Howell, R. W., Rao, D. V., Hou, D., Narra, V. R., & Sastry, K. S. R. (1991) · Radiation Research · doi:10.2307/3578051 · Cited by 89

Radioimmunotherapy with alpha-particle emitting radionuclides.

Zalutsky, M. R., & Pozzi, O. R. (2004) · PubMed · Cited by 88

Astatine-211—Tellurium Radiocolloid Cures Experimental Malignant Ascites

Bloomer, W. D., McLaughlin, W., Neirinckx, R. D., Adelstein, S. J., Gordon, P. R., Ruth, T. J., & Wolf, A. P. (1981) · Science · doi:10.1126/science.7209534 · Cited by 88

Inactivation of Synchronized Chinese Hamster V79 Cells with Charged-Particle Track Segments

Bird, R. P., Rohrig, N., Colvett, R. D., Geard, C. R., & Marino, S. A. (1980) · Radiation Research · doi:10.2307/3575379 · Cited by 88

Effective alpha-particle-mediated radioimmunotherapy of murine leukemia.

Huneke, R. B., Pippin, C. G., Squire, R. A., Brechbiel, M. W., Gansow, O. A., & Strand, M. (1992) · PubMed · Cited by 86

Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules

Adams, G. P., Shaller, C. C., Chappell, L. L., Wu, C., Horak, E. M., Simmons, H. H., Litwin, S., Marks, J. D., Weiner, L. M., & Brechbiel, M. W. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00103-7 · Cited by 83

1-(meta-[211At]Astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation

Vaidyanathan, G., & Zalutsky, M. R. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00018a006 · Cited by 83

Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-[211At]astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate

Hadley, S. W., Wilbur, D. S., Gray, M. A., & Atcher, R. W. (1991) · Bioconjugate Chemistry · doi:10.1021/bc00009a006 · Cited by 83

Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation

Harrison, J. D., & Muirhead, C. R. (2003) · International Journal of Radiation Biology · doi:10.1080/0955300021000038671 · Cited by 83

Synthesis, Conjugation, and Radiolabeling of a Novel Bifunctional Chelating Agent for 225Ac Radioimmunotherapy Applications

Chappell, L. L., Deal, K. A., Dadachova, E., & Brechbiel, M. W. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990153f · Cited by 82

Evaluation of 225 Ac for Vascular Targeted Radioimmunotherapy of Lung Tumors

Kennel, S. J., Chappell, L. L., Dadachova, K., Brechbiel, M. W., Lankford, T. K., Davis, I. A., Stabin, M. G., & Mirzadeh, S. (2000) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497800414329 · Cited by 82

211At radiocolloid therapy: Further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y

Bloomer, W. D., McLaughlin, W., Lambrecht, R. M., Atcher, R. W., Mirzadeh, S., Madara, J., Milius, R. A., Zalutsky, M. R., Adelstein, S. J., & Wolf, A. P. (1984) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(84)90052-x · Cited by 82

Thorotrast-induced cancer in man

Baserga, R., Yokoo, H., & Henegar, G. C. (1960) · Cancer · doi:10.1002/1097-0142(196009/10)13:5 · Cited by 81

Targeted cancer therapy with a novel low-dose rate α-emitting radioimmunoconjugate

Dahle, J., Borrebæk, J., Jónasdóttir, T. J., Hjelmerud, A. K., Melhus, K. B., Bruland, Ø. S., Press, O. W., & Larsen, R. H. (2007) · Blood · doi:10.1182/blood-2007-01-066803 · Cited by 80

The Radiation-Induced Bystander Effect for Clonogenic Survival

Sawant, S. G., Zheng, W., Hopkins, K. M., Randers-Pehrson, G., Lieberman, H. B., & Hall, E. J. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0361:tribef]2.0.co;2 · Cited by 80

Assessment of Low Linear Energy Transfer Radiation–Induced Bystander Mutagenesis in a Three-Dimensional Culture Model

Persaud, R., Zhou, H., Baker, S. E., Hei, T. K., & Hall, E. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2875 · Cited by 79

Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.

Zalutsky, M. R., McLendon, R. E., Garg, P., Archer, G. E., Schuster, J. M., & Bigner, D. D. (1994) · PubMed · Cited by 79

Improved point kernels for electron and beta-ray dosimetry

Berger, M. J. (1973) · doi:10.6028/nbs.ir.73-107 · Cited by 79

Mitigation of radiation nephropathy after internal α-particle irradiation of kidneys

Jaggi, J. S., Seshan, S. V., McDevitt, M. R., Sgouros, G., Hyjek, E. M., & Scheinberg, D. A. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.11.036 · Cited by 78

IN-VIVO RADIOTOXICITY OF DNA-INCORPORATED 125I COMPARED WITH THAT OF DENSELY IONISING ALPHA-PARTICLES

Rao, D., Howell, R. W., Narra, V. R., Govelitz, G. F., & Sastry, K. S. R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90896-9 · Cited by 78

Alpha- and beta-emitting radiolanthanides in targeted cancer therapy

Allen, B., & Blagojevic, N. (1996) · Nuclear Medicine Communications · doi:10.1097/00006231-199601000-00008 · Cited by 75

Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease

Milenic, D. E., Garmestani, K., Brady, E. D., Albert, P. S., Ma, D., Abdulla, A., & Brechbiel, M. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1226 · Cited by 75

213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model

Li, Y., Rizvi, S. M., Ranson, M., & Allen, B. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600179 · Cited by 73

Enhanced Loading Efficiency and Retention of225Ac in Rigid Liposomes for Potential Targeted Therapy of Micrometastases

Chang, M.-Y., Seideman, J. H., & Sofou, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700440a · Cited by 73

Effects of Different Ionizing Radiations on Human Cells in Tissue Culture: I. Irradiation Techniques and Dosimetry

Barendsen, G. W., & Beusker, T. L. J. (1960) · Radiation Research · doi:10.2307/3570858 · Cited by 73

Production routes of the alpha emitting 149 Tb for medical application

Beyer, G. J., Comor, J. J., Daković, M. Z., Soloviev, D., Tamburella, C., Hagebø, E., Allan, B., Dmitriev, S. N., & Zaitseva, N. G. (2002) · Radiochimica Acta · doi:10.1524/ract.2002.90.5_2002.247 · Cited by 72

Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.

Elgqvist, J., Andersson, H., Bäck, T. A., Hultborn, R., Jensen, H. J., Karlsson, B., Lindegren, S., Palm, S., Warnhammar, E., & Jacobsson, L. (2005) · PubMed · Cited by 72

Radioimmunotherapy of micrometastases in lung with vascular targeted213Bi

Kennel, S. J., Boll, R. A., Stabin, M. G., Schuller, H. M., & Mirzadeh, S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690337 · Cited by 70

Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.

Hartmann, F., Horak, E. M., Garmestani, K., Wu, C., Brechbiel, M. W., Kozak, R. W., Tso, J. Y., Kosteiny, S. A., Gansow, O. A., & Nelson, D. L. (1994) · PubMed · Cited by 70

Monoclonal antibodies : applications in clinical oncology

Epenetos, A. A. (1991) · Chapman & Hall Medical eBooks · Cited by 69

Generator-produced alpha-emitters

Mirzadeh, S. (1998) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(97)00175-9 · Cited by 69

A Generic Age-Specific Biokinetic Model for Calcium-like Elements

Leggett, R. W. (1992) · Radiation Protection Dosimetry · doi:10.1093/oxfordjournals.rpd.a081254 · Cited by 69

Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose.

Elgqvist, J., Andersson, H., Bäck, T. A., Claesson, I., Hultborn, R., Jensen, H. J., Johansson, B. R., Lindegren, S., Olsson, M., Palm, S., et al. (2006) · PubMed · Cited by 68

Induction of Sperm Head Abnormalities by Incorporated Radionuclides: Dependence on Subcellular Distribution, Type of Radiation, Dose Rate, and Presence of Radioprotectors

Rao, D. V., Narra, V. R., Howell, R. W., Lanka, V. K., & Sastry, K. S. R. (1991) · Radiation Research · doi:10.2307/3577986 · Cited by 68

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies

Nikula, T. K., Curcio, M. J., Brechbiel, M. W., Gansow, O. A., Finn, R. D., & Scheinberg, D. A. (1995) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)00126-5 · Cited by 67

The Promise of Targeted α-Particle Therapy

Mulford, D. A., Scheinberg, D. A., & Jurcic, J. G. (2005) · Journal of Nuclear Medicine · Cited by 67

Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle Emitter

Kennel, S. J., & Mirzadeh, S. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00200-x · Cited by 66

Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals.

Neti, P. V. S. V., & Howell, R. W. (2006) · PubMed · Cited by 66

The use of hypnosis in the care of the cancer patient

Butler, B. C. (1954) · Cancer · doi:10.1002/1097-0142(195401)7:1 · Cited by 65

Alpha-Emitters for Medical Therapy: Workshop of the United States Department of Energy: Denver, Colorado, May 30-31, 1996

Feinendegen, L. E., & McClure, J. J. (1997) · Radiation Research · doi:10.2307/3579579 · Cited by 65

Cell Survival Following Multiple-track Alpha Particle Irradiation

Lloyd, E. L., Gemmell, M. A., Henning, C. B., Gemmell, D. S., & Zabransky, B. J. (1979) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553007914550031 · Cited by 64

Radiotoxicity of Gadolinium-148 and Radium-223 in Mouse Testes: Relative Biological Effectiveness of Alpha-Particle Emitters In Vivo

Howell, R. W., Goddu, S. M., Narra, V. R., Fisher, D. R., Schenter, R. E., & Rao, D. V. (1997) · Radiation Research · doi:10.2307/3579342 · Cited by 62

Preclinical studies of targeted α therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2

Allen, B., Tian, Z., Rizvi, S. M., Li, Y., & Ranson, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600838 · Cited by 61

Preparation of a biologically stable and immunogenically competent astatinated protein

Friedman, A. M., Zalutsky, M. R., Wung, W. E., Buckingham, F. C., Harper, P. V., Scherr, G. H., Warner, B., Hunter, R. L., Appelman, E. H., Rothberg, R. M., et al. (1977) · International Journal of Nuclear Medicine and Biology · doi:10.1016/0047-0740(77)90146-2 · Cited by 60

Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate

Reist, C. J., Foulon, C. F., Alston, K. L., Bigner, D. D., & Zalutsky, M. R. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00120-6 · Cited by 60

Evidence for ‘bystander effects’ in vivo

Brooks, A. L. (2004) · Human & Experimental Toxicology · doi:10.1191/0960327104ht419oa · Cited by 59

Radioimmunotherapy with Alpha-Particle Emitters: Microdosimetry of Cells with a Heterogeneous Antigen Expression and with Various Diameters of Cells and Nuclei

Kvinnsland, Y., Stokke, T., & Aurlien, E. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0288:rwapem]2.0.co;2 · Cited by 59

Targeted alpha therapy for cancer

Allen, B., Raja, C., Rizvi, S. M., Li, Y., Tsui, W., Zhang, D., Song, E. Y., Qu, C. F., Kearsley, J. H., Graham, P., et al. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/16/016 · Cited by 58

Dose-dependent misrejoining of radiation-induced DNA double-strand breaks in human \nfibroblasts: Experimental and theoretical study for high and low LET radiation

Rydberg, B., Cooper, B., Cooper, P. K., Holley, W. R., & Chatterjee, A. (2004) · eScholarship (California Digital Library) · Cited by 58

Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy

Dahle, J., Borrebæk, J., Melhus, K. B., Bruland, Ø. S., Salberg, G., Olsen, D. R., & Larsen, R. H. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.12.004 · Cited by 57

Effect of 239 PuO 2 Particle Number and Size on the Frequency and Distribution of Chromosome Aberrations in the Liver of the Chinese Hamster

Brooks, A. L., Retherford, J. C., & McClellan, R. O. (1974) · Radiation Research · doi:10.2307/3574086 · Cited by 56

Production of terbium-152 by heavy ion reactions and proton induced spallation

Allen, B., Goozée, G., Sarkar, S., Beyer, G. J., Morel, C., & Byrne, A. P. (2001) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(00)00164-0 · Cited by 56

In Vivo Evaluation of Bismuth-Labeled Monoclonal Antibody Comparing DTPA-Derived Bifunctional Chelates

Milenic, D. E., Roselli, M., Mirzadeh, S., Pippin, C. G., Gansow, O. A., Colcher, D. M., Brechbiel, M. W., & Schlom, J. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801300189227 · Cited by 56

Energy deposition by protons and alpha particles in spherical sites of nanometer to micrometer diameter

Olko, P., & Booz, J. (1990) · Radiation and Environmental Biophysics · doi:10.1007/bf01211231 · Cited by 55

Model of DNA Damage Induced by Radiations of Various Qualities

Michalik, V. (1992) · International Journal of Radiation Biology · doi:10.1080/09553009214551781 · Cited by 55

An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation‐mediated bystander effects

Boyd, M., Mairs, R. J., Keith, W. N., Ross, S. C., Welsh, P. C., Akabani, G., Owens, J., Vaidyanathan, G., Carruthers, R., Dorrens, J., et al. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.578 · Cited by 55

Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.

Link, E. M., Brown, I., Carpenter, R. N., & Mitchell, J. S. (1989) · PubMed · Cited by 54

Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.

Strickland, D. K., Vaidyanathan, G., & Zalutsky, M. R. (1994) · PubMed · Cited by 54

Treatment of Neuroblastoma Meningeal Carcinomatosis with Intrathecal Application of α-Emitting Atomic Nanogenerators Targeting Disialo-Ganglioside GD2

Miederer, M., McDevitt, M. R., Borchardt, P. E., Bergman, I., Kramer, K., Cheung, N. V., & Scheinberg, D. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0859 · Cited by 54

Considerations of marrow cellularity in 3-dimensional dosimetric models of the trabecular skeleton.

Bolch, W. E., Patton, P. W., Rajon, D. A., Shah, A. P., Jokisch, D. W., & Inglis, B. A. (2002) · PubMed · Cited by 54

225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

Kratochwil, C., Bruchertseifer, F., Giesel, F. L., Weis, M., Verburg, F. A., Mottaghy, F. M., Kopka, K., Apostolidis, C., Haberkorn, U., & Morgenstern, A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178673 · Cited by 1,187

Radiopharmaceutical therapy in cancer: clinical advances and challenges

Sgouros, G., Bodei, L., McDevitt, M. R., & Nedrow, J. R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0073-9 · Cited by 1,032

Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding

Kratochwil, C., Bruchertseifer, F., Rathke, H., Bronzel, M., Apostolidis, C., Weichert, W., Haberkorn, U., Giesel, F. L., & Morgenstern, A. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191395 · Cited by 505

213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience

Kratochwil, C., Giesel, F. L., Bruchertseifer, F., Mier, W., Apostolidis, C., Boll, R. A., Murphy, K., Haberkorn, U., & Morgenstern, A. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2857-9 · Cited by 418

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

Morgenstern, A., Apostolidis, C., Kratochwil, C., Sathekge, M. M., Królicki, L., & Bruchertseifer, F. (2018) · Current Radiopharmaceuticals · doi:10.2174/1874471011666180502104524 · Cited by 382

SPECIAL CONTRIBUTION MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of a-Particle Emitters for Targeted Radionuclide Therapy*

Sgouros, G., Roeske, J. C., McDevitt, M. R., Palm, S., Allen, B. J., Fisher, D. R., Bertr, A., Hong, S., Howell, R. W., Akabani, G., et al. (2013)

Targeted and Nontargeted α-Particle Therapies

McDevitt, M. R., Sgouros, G., & Sofou, S. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-120931 · Cited by 76

Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations

Makvandi, M., Dupis, E., Engle, J. W., Nortier, F. M., Fassbender, M. E., Simon, S., Birnbaum, E. R., Atcher, R. W., John, K. D., Rixe, O., et al. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0550-9 · Cited by 173

Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides

Sgouros, G., Hobbs, R. F., & Josefsson, A. (2018) · Current Radiopharmaceuticals · doi:10.2174/1874471011666180426130058 · Cited by 33

High-LET-Emitting Radionuclides for Cancer Therapy

Sgouros, G. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8696-0_9 · Cited by 1